Onco Therapies Limited (OTL), the wholly-owned oncology subsidiary of Strides, has received the UK's approval for Oxaliplatin injections in strengths of 5 mg per 10 ml, 5 mg per 20 ml and 5 mg per 40 ml, Strides Arcolab said in a statement.
"The current approval is from UK and approval for the rest of the European countries is expected shortly," it added.
7999
15998
301
418
449
599
500
1998
2050
4099
500
999
748
2200
4019
7999
695
1999
7178
14356
3311
3599
1299
2599
10800
16200